Table 4.
Group | n | vWF | GFAP | NeuN |
---|---|---|---|---|
Sham group | 3 | 7.33 ± 2.51 | 2222.24 ± 481.44 | 46.67 ± 8.74 |
CIRU group | 3 | 11.33* ± 2.52 | 2936.06 ± 703.33 | 47.67 ± 8.14 |
Scu-50 group | 3 | 13.0* ± 1.00 | 3438.27* ± 805.82 | 75.00∗∗,w,∗∗∗ ± 6.08 |
Scu-25 group | 3 | 10.0* ± 1.00 | 3509.09* ± 281.83 | 48.33 ± 5.51 |
Nimodipine group | 3 | 14.0* ± 1.73 | 3016.93 ± 113.45 | 59.67 ± 8.33 |
Values are means ± SD.
*P < 0.05; significantly lower compared with values of sham group.
**P < 0.01; significantly higher compared with values of Scu-25 group.
***P < 0.001; significantly higher compared with values of CIRU group.
w P < 0.05; significantly higher compared with values of nimodipine group.